Xu, Huafeng
Article History
Received: 1 November 2022
Accepted: 28 November 2022
First Online: 5 December 2022
Declarations
:
: Huafeng Xu is a shareholder of Stingthera, which is conducting clinical trials of the STING agonist described in reference [CitationRef removed]. Huafeng Xu is the sole author of this paper.